Medical News

RSS

New initiative to help improve oral health for North Carolina children

The North Carolina Head Start-State Collaboration Office and the American Academy of Pediatric Dentistry (AAPD), today announced the launch of the Head Start Dental Home Initiative to improve oral health for North Carolina children.

20 Nov 2010

Data from Rockwell Medical's Phase IIb study of SFP presented at ASN meeting

Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia, announced today that the Company will present new data at the American Society of Nephrology meeting being held in Denver, Colorado, on its late-stage investigational drug Soluble Ferric Pyrophosphate, which is being studied for the treatment of iron-deficiency anemia in ESRD patients.

20 Nov 2010

Allos Therapeutics to present FOLOTYN data for blood cancers at ASH Annual Meeting

Allos Therapeutics, Inc. today announced that five abstracts, describing FOLOTYN (pralatrexate injection) data across different types of blood cancers, were accepted in the program for this year's 52nd American Society of Hematology (ASH) Annual Meeting to be held December 4-7, 2010, in Orlando, Florida.

20 Nov 2010

MedSynergies receives gold-level award for website design

MedSynergies Inc., the leading provider of hospital-physician alignment solutions, received the gold-level award for achieving the best website design in the Corporate Business Improvement Site division of the 2010 eHealthcare Leadership Awards.

20 Nov 2010

PROTOX closes first tranche of investment by Warburg Pincus

Protox Therapeutics Inc., a leader in the development of receptor targeted therapeutic fusion proteins, today announced it has closed the first tranche of the investment by Warburg Pincus. The investment was approved by 100% of the votes cast by shareholders at the recent special shareholders meeting.

20 Nov 2010

USC Norris designated Phase I Clinical Trial Center of Excellence

The USC Norris Comprehensive Cancer Center (USC Norris) has been designated a Phase I Clinical Trial Center of Excellence by global pharmaceutical company Bristol-Myers Squibb Company. The collaboration will bring a number of new phase I clinical trials to USC Norris, and will enable the cancer center's clinical and basic scientists to provide guidance in early phase drug development and trial design.

20 Nov 2010

Thorax Institute presents 18-year experience with SynCardia Artificial Heart at Acute Cardiac Care meeting

On Oct. 17, Dr. Jean Christian Roussel from the Thorax Institute at University Hospital of Nantes presented the center's 18-year experience with the SynCardia temporary Total Artificial Heart at the Acute Cardiac Care 2010 medical meeting in Copenhagen, Denmark.

20 Nov 2010

Evelyn Y. Davis gifts $100,000 to Swedish Medical Center

Swedish Medical Center announced today that it has received an unrestricted $100,000 gift from nationally known shareholder advocate Evelyn Y. Davis and the Evelyn Y. Davis Foundation. Since establishing her Foundation in 1989, Davis – who is from Washington, D.C. – has now made significant donations across the country to leading medical centers, nationally prominent universities, and various arts organizations.

20 Nov 2010

CombiMatrix receives Nasdaq noncompliance notice

CombiMatrix Corporation today announced that it received a written notice from The Nasdaq Stock Market (the "Notice") on November 17, 2010 indicating that the Company is not in compliance with the minimum stockholders' equity requirement for continued listing on The Nasdaq Global Market (as set forth in Nasdaq Listing Rule 5450(b)(1)(A)) because the Company's stockholders' equity is below The Nasdaq Global Market minimum stockholders' equity listing requirement of $10,000,000.

20 Nov 2010

Tackling physical, mental health of prisoners would improve public health, researchers say

Providing the more than 10 million people incarcerated around the world "with better health care could prevent outbreaks of HIV and tuberculosis from spilling over into the general population experts say," the Associated Press/Washington Post reports.

20 Nov 2010

PIPC's white paper provides guidance in defining CER procedures

The Partnership to Improve Patient Care today released a white paper that defines a Procedural Framework for the Conduct of Comparative Effectiveness Research. The paper and its executive summary provide guidance for policy-makers, patient and providers for establishing CER procedures that foster openness, transparency and patient-centeredness.

20 Nov 2010

One-third of malaria-endemic countries are complying with WHO malaria drug efficacy monitoring standards, report says

Thirty-four percent of malaria-endemic countries are complying with WHO guidelines to monitor artemisinin resistance within their borders, the agency said in a report on Thursday, CBS News reports (11/18). Reuters reports that artemisinin "is the best drug available against malaria, especially when used in artemisinin combination therapy (ACT), which combines it with other drugs that finish off the [malaria] parasite" (Nebehay, 11/18).

20 Nov 2010

Pfizer's Phase 3 AXIS 1032 trial for metastatic renal cell carcinoma meets primary endpoint

Pfizer Inc. announced today that the Phase 3 AXIS 1032 trial (A4061032), studying the investigational compound axitinib in previously treated patients with metastatic renal cell carcinoma (mRCC), has met its primary endpoint, demonstrating that axitinib significantly extended progression-free survival when compared to sorafenib, in the study population.

20 Nov 2010

UH physicists study workings of PGK enzyme that may cause Alzheimer's, cancer

University of Houston physicists are using complex computer simulations to illuminate the workings of a crucial protein that, when malfunctioning, may cause Alzheimer's and cancer.

20 Nov 2010

Platelet Rich Plasma Therapy reduces pain and improves function in knee osteoarthritis patients

The first American study that positions Platelet Rich Plasma Therapy (PRP) as a viable means in managing knee osteoarthritis, appeared today in the December issue of the American Journal of Physical Medicine & Rehabilitation (AJPMR). The study, authored by Dr. Steven Sampson of the Orthohealing Center in Los Angeles, details the account of 14 patients with primary and secondary knee osteoarthritis receiving three platelet-rich plasma injections in the affected knee at 4-week intervals with one year follow up.

20 Nov 2010

Siemens to unveil Biograph mMR system at RSNA Annual Meeting

At the 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), November 28 - December 2 in Chicago, Siemens Healthcare (Booth #822, East Building/Lakeside Center, Hall D) will unveil the Biograph mMR, the world's first integrated whole-body molecular Magnetic Resonance (MR) system with simultaneous data acquisition technology, currently undergoing clinical use testing.

20 Nov 2010

VeriStrat analysis shows patients with advanced NSCLC benefit from dual targeted therapies

Results from the VeriStrat analysis of a phase II trial of first line erlotinib in combination with sorafenib in patients with advanced non-small cell lung cancer were presented today at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets in Cancer Therapeutics being held in Berlin, Germany by Egbert Smit, MD, PhD of the VU Medical Center, Amsterdam, The Netherlands.

20 Nov 2010

Discovery could provide new approaches to treat metabolic disorders

Scientists from the Florida campus of The Scripps Research Institute have identified a novel synthetic activator of a pair of proteins that belong to a protein family playing key roles in human metabolism and immune function. The discovery could provide new and potentially more effective therapeutic approaches to diseases ranging from diabetes to osteoporosis.

20 Nov 2010

IMRIS common shares commence trading on NASDAQ Global Market

IMRIS Inc. announced today that its common shares have commenced trading on the NASDAQ Global Market under the symbol "IMRS". IMRIS' common shares are dual listed on the Toronto Stock Exchange and the NASDAQ Global Market.

20 Nov 2010

Repeal, replace and revise are the new health overhaul buzzwords as congressional power changes hands

Senate Minority Leader Mitch McConnell and 32 other GOP senators officially filed a brief on Thursday in favor of a court case challenging healthcare reform. McConnell filed a 16-page brief in a federal case based in Florida arguing that a key part of the new healthcare law, the requirement that all individuals have health insurance, was unconstitutional.

20 Nov 2010

Medical News

New initiative to help improve oral health for North Carolina children

Data from Rockwell Medical's Phase IIb study of SFP presented at ASN meeting

Allos Therapeutics to present FOLOTYN data for blood cancers at ASH Annual Meeting

MedSynergies receives gold-level award for website design

PROTOX closes first tranche of investment by Warburg Pincus

USC Norris designated Phase I Clinical Trial Center of Excellence

Thorax Institute presents 18-year experience with SynCardia Artificial Heart at Acute Cardiac Care meeting

Evelyn Y. Davis gifts $100,000 to Swedish Medical Center

CombiMatrix receives Nasdaq noncompliance notice

Tackling physical, mental health of prisoners would improve public health, researchers say

PIPC's white paper provides guidance in defining CER procedures

One-third of malaria-endemic countries are complying with WHO malaria drug efficacy monitoring standards, report says

Pfizer's Phase 3 AXIS 1032 trial for metastatic renal cell carcinoma meets primary endpoint

UH physicists study workings of PGK enzyme that may cause Alzheimer's, cancer

Platelet Rich Plasma Therapy reduces pain and improves function in knee osteoarthritis patients

Siemens to unveil Biograph mMR system at RSNA Annual Meeting

VeriStrat analysis shows patients with advanced NSCLC benefit from dual targeted therapies

Discovery could provide new approaches to treat metabolic disorders

IMRIS common shares commence trading on NASDAQ Global Market

Repeal, replace and revise are the new health overhaul buzzwords as congressional power changes hands

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News